Earnings Forecast: Companies to Report Before and After the Bell

Earnings Forecast: Several companies are set to release quarterly earnings reports, including Franco-Nevada and BioNTech. Market reactions may vary based on performance relative to expectations.

Date: 10-03-2025

AI Rating: 6

**Earnings Per Share and Revenue Growth Analysis**

Franco-Nevada (FNV) is anticipated to report earnings of $0.89 per share alongside revenues of $305.85 million, indicative of possibly positive investor sentiment due to both expected profitability and substantial revenue.

On the other hand, BioNTech (BNTX) is projected to have quarterly earnings of $0.37 per share with revenues estimated at $1.15 billion, which can boost confidence in the company as it posts a positive EPS with strong revenue figures.

UroGen Pharma (URGN) is set to report a loss of $0.72 per share with modest revenues of $25.25 million, which may negatively impact stock prices as it shows significant losses.

DarioHealth (DRIO) and Fennec Pharmaceuticals (FENC) are also expected to incur losses and generate lower revenues, which may contribute to further downward pressure on their stock valuations.

In contrast, Ramaco Resources (METC) forecasts earnings of $0.04 per share on $176.04 million in revenue, which is relatively low but still represents a modest expectation amidst other companies reporting losses.

Grupo Supervielle (SUPV) anticipates earnings of $0.25 per share with $215.50 million in revenue, potentially indicating a positive outlook for investors.

Various companies report losses with projected EPS ranges from -$0.03 to -$0.72, casting a shadow over investor confidence, especially for companies like Aligos Therapeutics (ALGS) and Douglas Elliman (DOUG).

Overall, the mixed bag of earnings reports could lead to volatile trading post-announcement as investor reactions are likely to vary significantly based on performance against expectations.

Stocks: FNV BNTX URGN DRIO FENC METC SUPV DOUG